These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27846625)

  • 21. Chronobiological aspects of nutrition, metabolic syndrome and obesity.
    Garaulet M; Madrid JA
    Adv Drug Deliv Rev; 2010 Jul; 62(9-10):967-78. PubMed ID: 20580916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype.
    Flachs P; Rossmeisl M; Kuda O; Kopecky J
    Biochim Biophys Acta; 2013 May; 1831(5):986-1003. PubMed ID: 23454373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronobesity: role of the circadian system in the obesity epidemic.
    Laermans J; Depoortere I
    Obes Rev; 2016 Feb; 17(2):108-25. PubMed ID: 26693661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronomics complement, among many other fields, genomics and proteomics.
    Halberg F; Cornélissen G; Katinas G; Hillman D; Schwartzkopff O;
    Neuro Endocrinol Lett; 2001; 22(1):53-73. PubMed ID: 11393163
    [No Abstract]   [Full Text] [Related]  

  • 25. Chronobiology and obesity: Interactions between circadian rhythms and energy regulation.
    Summa KC; Turek FW
    Adv Nutr; 2014 May; 5(3):312S-9S. PubMed ID: 24829483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice.
    Caton PW; Kieswich J; Yaqoob MM; Holness MJ; Sugden MC
    Diabetes Obes Metab; 2011 Dec; 13(12):1097-104. PubMed ID: 21733059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Update of Obesity Syndrome: Molecular Mechanism, Pathophysiology and Therapies. Topics: I. Recent Topics on Diagnosis and Pathophysiology of the Obesity Syndrome; 4. Circadian rhythm disorders and obesity].
    Yamaoka M; Shimomura I
    Nihon Naika Gakkai Zasshi; 2015 Apr; 104(4):710-6. PubMed ID: 26536733
    [No Abstract]   [Full Text] [Related]  

  • 28. Circadian clock and cardiovascular disease.
    Takeda N; Maemura K
    J Cardiol; 2011 May; 57(3):249-56. PubMed ID: 21441015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.
    Gucalp A; Iyengar NM; Hudis CA; Dannenberg AJ
    Semin Oncol; 2016 Feb; 43(1):154-160. PubMed ID: 26970134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of adrenalectomy on daily gene expression rhythms in the rat suprachiasmatic and paraventricular hypothalamic nuclei and in white adipose tissue.
    Su Y; van der Spek R; Foppen E; Kwakkel J; Fliers E; Kalsbeek A
    Chronobiol Int; 2015 Mar; 32(2):211-24. PubMed ID: 25268283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circadian clock disruptions and the risk of cancer.
    Lahti T; Merikanto I; Partonen T
    Ann Med; 2012 Dec; 44(8):847-53. PubMed ID: 23072403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased lipogenesis in white adipose tissue contributes to the resistance to high fat diet-induced obesity in phosphatidylethanolamine N-methyltransferase-deficient mice.
    Gao X; van der Veen JN; Hermansson M; Ordoñez M; Gomez-Muñoz A; Vance DE; Jacobs RL
    Biochim Biophys Acta; 2015 Feb; 1851(2):152-62. PubMed ID: 25463480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals.
    Badoud F; Perreault M; Zulyniak MA; Mutch DM
    FASEB J; 2015 Mar; 29(3):748-58. PubMed ID: 25411437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the molecular circadian clock in human energy homeostasis.
    Dollet L; Pendergrast LA; Zierath JR
    Curr Opin Lipidol; 2021 Feb; 32(1):16-23. PubMed ID: 33278080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Circadian clock disruption and diabetes mellitus].
    Ando H; Fujimura A
    Nihon Rinsho; 2013 Dec; 71(12):2114-8. PubMed ID: 24437264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian clock and cancer therapy: an unexpected journey.
    Kondratov R
    Ann Med; 2014 Jun; 46(4):189-90. PubMed ID: 24915534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adipose circadian rhythms: translating cellular and animal studies to human physiology.
    Johnston JD
    Mol Cell Endocrinol; 2012 Feb; 349(1):45-50. PubMed ID: 21664232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing to perfection: the biology of central and peripheral circadian clocks.
    Albrecht U
    Neuron; 2012 Apr; 74(2):246-60. PubMed ID: 22542179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clock desynchronisation: why and how?
    Ouitou Y
    Bull Acad Natl Med; 2015 Oct; 199(7):1073-1080. PubMed ID: 29879329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular disease, chronopharmacotherapy, and the molecular clock.
    Takeda N; Maemura K
    Adv Drug Deliv Rev; 2010 Jul; 62(9-10):956-66. PubMed ID: 20451570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.